[The drug treatment of "myopia syndrome" (author's transl)].
46 patients with myopia syndrome were treated for over two years with Difrarel E and Neosynephrin 5%. Three patients discontinued treatment. Only in one case deterioration occured. All remaining patients showed none or only slight changes of the refraction during the treatment period.
D000293:Adolescent; D000328:Adult; D000872:Anthocyanins / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D009216:Myopia / Q000188:drug therapy*; D010656:Phenylephrine / Q000494:pharmacology / Q000627:therapeutic use; D012029:Refraction, Ocular; D013577:Syndrome; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use
D000872:Anthocyanins; D004338:Drug Combinations; D014810:Vitamin E; D010656:Phenylephrine
Medikamentöse Behandlung des "Myopie-Syndroms".